Color Health

Color Genomics is a precision genomics company that offers direct-to-consumer and B2B genetic testing services and provides insights into patient health risks in areas such as heart disease and cancer. The company’s physician-ordered tests can be requested via its online platform, following which a sample collection kit is sent to the individual. Customers can choose between a hereditary cancer test that analyzes the sample for 30 genes associated with eight common hereditary cancers and the color extended test which identifies variants in 74 genes related to hereditary cancers, heart disease, and medication response. The color extended test kits are priced at USD 234. Individuals also have access to board-certified genetic counselors for a consultation through the platform.

The company collaborates directly with employers, unions, health systems, and governments to offer healthcare services related to preventive health and infectious disease management. By January 2021, its clients included Teamsters Union, the National Institutes of Health, Salesforce, the State of California, and United Airlines. In addition, the company offers Covid-19 testing, screening, and vaccine management services for large populations.

Funding and financials

The company raised USD 100 million in a Series E funding round in November 2021 led by Kindred Ventures, which valued the startup at USD 4.6 billion. The new funds were allocated toward expanding access to screening, diagnostics and treatments for individuals. The firm offerings will include vaccination and preventative health services for schools and employers, and it planned to offer infectious disease management programs in the future. The new funds came under a year since its Series D round (January 2021) which propelled it to unicorn status.